Home › GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Mercks HPV Vaccine, Available to Developing Countries through UNICEF Tender
 

Keywords :   


GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Mercks HPV Vaccine, Available to Developing Countries through UNICEF Tender

2013-05-09 13:20:00| Merck.com - Product News

Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company has been awarded a significant portion of the UNICEF human papillomavirus (HPV) vaccine tender, and will provide sustained supply of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] to GAVI-eligible countries. This agreement follows the GAVI Alliances earlier announcement that HPV vaccines would be included in its portfolio for the first time. Language:  English Contact HTML:  MerckMedia:Pamela Eisele, 908-423-5042orImraan Munshi, 215-652-0059orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: to through types human

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.11Natracare Launches E-Commerce Site
04.11Tropical Depression Eighteen Graphics
04.11The Honey Pot Launches Witch Hazel Intimate Wash & Wipes
04.11Remnants of Patty Graphics
04.11Tropical Depression Eighteen Forecast Discussion Number 4
04.11Remnants of Patty Forecast Discussion Number 10
04.11Remnants of Patty Wind Speed Probabilities Number 10
04.11Remnants of Patty Public Advisory Number 10
More »